Increased Enzymatic Activity of Acetylcholinesterase Indicates the Severity of the Sterile Inflammation and Predicts Patient Outcome following Traumatic Injury.

Aleksandar R Zivkovic, Georgina M Paul, Stefan Hofer, Karsten Schmidt, Thorsten Brenner, Markus A Weigand, Sebastian O Decker
Author Information
  1. Aleksandar R Zivkovic: Department of Anesthesiology, Heidelberg University Hospital, 69120 Heidelberg, Germany. ORCID
  2. Georgina M Paul: Department of Anesthesiology, Heidelberg University Hospital, 69120 Heidelberg, Germany.
  3. Stefan Hofer: Clinic for Anesthesiology, Intensive Care, Emergency Medicine I and Pain Therapy, Westpfalz Hospital, 67661 Kaiserslautern, Germany.
  4. Karsten Schmidt: Department of Anesthesiology and Intensive Care Medicine, University Hospital Essen, University of Duisburg-Essen, 45147 Essen, Germany. ORCID
  5. Thorsten Brenner: Department of Anesthesiology and Intensive Care Medicine, University Hospital Essen, University of Duisburg-Essen, 45147 Essen, Germany.
  6. Markus A Weigand: Department of Anesthesiology, Heidelberg University Hospital, 69120 Heidelberg, Germany.
  7. Sebastian O Decker: Department of Anesthesiology, Heidelberg University Hospital, 69120 Heidelberg, Germany. ORCID

Abstract

Traumatic injury induces sterile inflammation, an immune response often associated with severe organ dysfunction. The cholinergic system acts as an anti-inflammatory in injured patients. Acetylcholinesterase (AChE), an enzyme responsible for the hydrolysis of acetylcholine, plays an essential role in controlling cholinergic activity. We hypothesized that a change in the AChE activity might indicate the severity of the traumatic injury. This study included 82 injured patients with an Injury Severity Score (ISS) of 4 or above and 40 individuals without injuries. Bedside-measured AChE was obtained on hospital arrival, followed by a second measurement 4-12 h later. C-reactive protein (CRP), white blood cell count (WBCC), and Sequential Organ Failure Assessment (SOFA) score were simultaneously collected. Injured patients showed an early and sustained increase in AChE activity. CRP remained unaffected at hospital admission and increased subsequently. Initially elevated WBCC recovered 4-12 h later. AChE activity directly correlated with the ISS and SOFA scores and predicted the length of ICU stay when measured at hospital admission. An early and sustained increase in AChE activity correlated with the injury severity and could predict the length of ICU stay in injured patients, rendering this assay a complementary diagnostic and prognostic tool at the hand of the attending clinician in the emergency unit.

Keywords

References

  1. Neurosci Lett. 1999 Jan 8;259(2):71-4 [PMID: 10025560]
  2. J Pharmacol Sci. 2017 May;134(1):1-21 [PMID: 28552584]
  3. Am J Physiol. 1998 Jun;274(6):L970-9 [PMID: 9609736]
  4. J Zhejiang Univ Sci B. 2014 Dec;15(12):1023-31 [PMID: 25471831]
  5. Front Immunol. 2018 Apr 13;9:754 [PMID: 29706967]
  6. J Trauma. 1996 Apr;40(4):501-10; discussion 510-2 [PMID: 8614027]
  7. J Trauma Acute Care Surg. 2014 Mar;76(3):582-92, discussion 592-3 [PMID: 24553523]
  8. Lancet. 2010 Nov 27;376(9755):1829-37 [PMID: 21056464]
  9. Acta Neuropathol Commun. 2015 Nov 04;3:67 [PMID: 26531194]
  10. Emerg (Tehran). 2014 Spring;2(2):90-5 [PMID: 26495354]
  11. Crit Care. 2006 Feb;10(1):R1 [PMID: 16356205]
  12. Mediators Inflamm. 2015;2015:274607 [PMID: 25762852]
  13. Diagnostics (Basel). 2022 Sep 03;12(9): [PMID: 36140551]
  14. Burns. 2002 Mar;28(2):147-50 [PMID: 11900938]
  15. Int Immunopharmacol. 2015 Nov;29(1):127-34 [PMID: 25907239]
  16. Neuropharmacology. 2020 May 15;168:108020 [PMID: 32143069]
  17. Med Sci Monit. 2007 Dec;13(12):RA214-21 [PMID: 18049445]
  18. Mediators Inflamm. 2018 Apr 29;2018:1942193 [PMID: 29853783]
  19. Adv Clin Chem. 2009;48:111-36 [PMID: 19803417]
  20. Sci Rep. 2019 Jul 18;9(1):10437 [PMID: 31320703]
  21. Eur J Pharmacol. 2008 Mar 17;582(1-3):145-53 [PMID: 18242599]
  22. Crit Care. 2022 Dec 6;26(1):377 [PMID: 36474266]
  23. Neuropharmacology. 2006 Apr;50(5):540-7 [PMID: 16336980]
  24. Eur J Anaesthesiol. 2019 Feb;36(2):114-122 [PMID: 30431498]
  25. J Inflamm Res. 2016 Nov 18;9:221-230 [PMID: 27920568]
  26. J Gerontol A Biol Sci Med Sci. 2008 Jul;63(7):764-72 [PMID: 18693233]
  27. BMC Anesthesiol. 2020 Nov 17;20(1):287 [PMID: 33203376]
  28. J Trauma. 1974 Mar;14(3):187-96 [PMID: 4814394]
  29. Biomolecules. 2022 Jul 15;12(7): [PMID: 35883545]
  30. Crit Care Med. 2009 May;37(5):1762-8 [PMID: 19325490]
  31. Clin Chim Acta. 1966 Oct;14(4):435-41 [PMID: 4961663]
  32. Toxicol Lett. 2016 May 13;249:22-8 [PMID: 27033775]
  33. Ann Clin Biochem. 1989 Jan;26 ( Pt 1):49-57 [PMID: 2472099]
  34. Brain Stimul. 2016 Mar-Apr;9(2):225-33 [PMID: 26515786]
  35. Clin Toxicol (Phila). 2019 Jun;57(6):411-414 [PMID: 30451024]
  36. J Mol Neurosci. 2014 Jul;53(3):298-305 [PMID: 24254221]
  37. BMC Neurol. 2008 Sep 20;8:34 [PMID: 18803862]
  38. Burns. 2021 Jun;47(4):863-872 [PMID: 33248805]
  39. Pharmacotherapy. 2005 Nov;25(11):1592-601 [PMID: 16232021]
  40. Prog Brain Res. 1969;31:241-5 [PMID: 4899409]
  41. Clin Chem Lab Med. 2011 Mar;49(3):493-9 [PMID: 21275817]
  42. West J Emerg Med. 2008 May;9(2):81-5 [PMID: 19561712]
  43. Eur J Trauma Emerg Surg. 2018 Apr;44(Suppl 1):3-271 [PMID: 29654333]
  44. J Intern Med. 2020 Feb;287(2):120-133 [PMID: 31710126]
  45. Am Fam Physician. 2000 Nov 1;62(9):2053-60 [PMID: 11087187]
  46. Adv Ther. 2007 Sep-Oct;24(5):955-62 [PMID: 18029320]
  47. Front Immunol. 2018 Jul 30;9:1604 [PMID: 30105015]
  48. Life Sci. 2003 Mar 28;72(18-19):2101-9 [PMID: 12628464]
  49. Nat Rev Neurosci. 2001 Apr;2(4):294-302 [PMID: 11283752]
  50. Front Immunol. 2017 Sep 06;8:1085 [PMID: 28932225]
  51. Crit Care Med. 2015 Sep;43(9):1846-52 [PMID: 26010688]
  52. Br J Surg. 1998 Jul;85(7):986-90 [PMID: 9692580]
  53. J Immunol. 2009 Jul 1;183(1):552-9 [PMID: 19542466]
  54. J Surg Res. 2017 Dec;220:275-283 [PMID: 29180192]
  55. Pharmacol Ther. 2017 Nov;179:1-16 [PMID: 28529069]
  56. J Nucl Med. 2022 Jun;63(Suppl 1):33S-44S [PMID: 35649648]
  57. J Intensive Care. 2017 May 26;5:29 [PMID: 28560042]
  58. Intensive Care Med. 1996 Jul;22(7):707-10 [PMID: 8844239]
  59. Prog Brain Res. 1996;109:55-65 [PMID: 9009693]
  60. Clin Hemorheol Microcirc. 2013;53(1-2):209-16 [PMID: 23187452]
  61. Molecules. 2017 Sep 08;22(9): [PMID: 28885588]
  62. Brain Behav Immun. 2009 Jan;23(1):41-5 [PMID: 18639629]
  63. Curr Surg. 2003 Nov-Dec;60(6):632-5 [PMID: 14972206]
  64. Blood Transfus. 2017 May;15(3):232-238 [PMID: 28518050]

MeSH Term

Humans
Acetylcholinesterase
Hospitalization
Injury Severity Score
Inflammation

Chemicals

Acetylcholinesterase

Word Cloud

Created with Highcharts 10.0.0AChEactivitypatientsinjurycholinergicinjuredhospitalTraumaticanti-inflammatoryAcetylcholinesteraseacetylcholineseverityInjurySeverityISS4-12hlaterCRPWBCCSOFAearlysustainedincreaseadmissioncorrelatedlengthICUstayinducessterileinflammationimmuneresponseoftenassociatedsevereorgandysfunctionsystemactsenzymeresponsiblehydrolysisplaysessentialrolecontrollinghypothesizedchangemightindicatetraumaticstudyincluded82Score440individualswithoutinjuriesBedside-measuredobtainedarrivalfollowedsecondmeasurementC-reactiveproteinwhitebloodcellcountSequentialOrganFailureAssessmentscoresimultaneouslycollectedInjuredshowedremainedunaffectedincreasedsubsequentlyInitiallyelevatedrecovereddirectlyscorespredictedmeasuredpredictrenderingassaycomplementarydiagnosticprognostictoolhandattendingclinicianemergencyunitIncreasedEnzymaticActivityIndicatesSterileInflammationPredictsPatientOutcomefollowingpathwaypoint-of-caretestingtrauma

Similar Articles

Cited By